| Literature DB >> 25017970 |
Ruijuan Zhao1, Hongyan Zhou1, Jing Zhang1, Xialin Liu1, Shao Bo Su2.
Abstract
Interleukin-1β (IL-1β) is a potent proinflammatory cytokine that plays a critical role in initiating immunoinflammatory responses. In this study, we generated recombinant mouse IL-1β and anti-mouse IL-1β polyclonal antibodies to examine the effect of IL-1β on experimental autoimmune uveoretinitis (EAU), a mouse model for T cell-mediated eye autoimmune disease. Administration of mouse IL-1β by i.p. in the priming phase, but not in the effector phase, of immune response of EAU enhanced disease scores and its related immune responses including DTH, Ag-specific T cell proliferation and the production of IL-17 and IFN-γ. Furthermore, administration of anti-IL-1β antibody in the priming phase reduced EAU scores. These results suggest that IL-1β is an important mediator in the pathogenesis of autoimmune diseases such as uveitis.Entities:
Keywords: Anti-IL-1β therapy; IL-1β; Priming phase; Uveitis
Mesh:
Substances:
Year: 2014 PMID: 25017970 DOI: 10.1016/j.intimp.2014.06.041
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932